TRex Bio, Inc. ("TRexBio"), a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology, today announced that the first patient has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results